157 related articles for article (PubMed ID: 35729851)
21. Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years.
van Zeventer IA; Salzbrunn JB; de Graaf AO; van der Reijden BA; Boezen HM; Vonk JM; van der Harst P; Schuringa JJ; Jansen JH; Huls G
Blood Adv; 2021 Apr; 5(8):2115-2122. PubMed ID: 33877299
[TBL] [Abstract][Full Text] [Related]
22. Clonal haematopoiesis mutations in cardiogenic shock: a beginning of a new era?
Deniau B; Asakage A; Mebazaa A
Eur J Heart Fail; 2022 Sep; 24(9):1583-1585. PubMed ID: 35851515
[No Abstract] [Full Text] [Related]
23. Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?
Kusne Y; Fernandez J; Patnaik MM
Semin Hematol; 2021 Oct; 58(4):226-229. PubMed ID: 34802544
[TBL] [Abstract][Full Text] [Related]
24. The Th17/Treg imbalance in patients with cardiogenic shock.
del Rosario Espinoza Mora M; Böhm M; Link A
Clin Res Cardiol; 2014 Apr; 103(4):301-13. PubMed ID: 24374759
[TBL] [Abstract][Full Text] [Related]
25. Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.
Ahn HJ; An HY; Ryu G; Lim J; Sun C; Song H; Choi SY; Lee H; Maurer T; Nachun D; Kwon S; Lee SR; Lip GYH; Oh S; Jaiswal S; Koh Y; Choi EK
Eur Heart J; 2024 Mar; 45(10):778-790. PubMed ID: 38231881
[TBL] [Abstract][Full Text] [Related]
26. Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.
Prondzinsky R; Unverzagt S; Lemm H; Wegener N; Heinroth K; Buerke U; Fiedler M; Thiery J; Haerting J; Werdan K; Buerke M
Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):476-84. PubMed ID: 22810435
[TBL] [Abstract][Full Text] [Related]
27. Short- and Long-Term Prognostic Relevance of Cardiogenic Shock in Takotsubo Syndrome: Results From the RETAKO Registry.
Almendro-Delia M; Núñez-Gil IJ; Lobo M; Andrés M; Vedia O; Sionis A; Martin-García A; Cruz Aguilera M; Pereyra E; Martín de Miguel I; Linares Vicente JA; Corbí-Pascual M; Bosch X; Fabregat Andrés O; Sánchez Grande Flecha A; Pérez-Castellanos A; Pais JL; De Mora Martín M; Escudier Villa JM; Martín Asenjo R; Guillen Marzo M; Rueda Sobella F; Aceña Á; García Acuña JM; García-Rubira JC;
JACC Heart Fail; 2018 Nov; 6(11):928-936. PubMed ID: 30316938
[TBL] [Abstract][Full Text] [Related]
28. Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse.
Newell LF; Williams T; Liu J; Yu Y; Chen Y; Booth GC; Knight RJ; Goslee KR; Cook RJ; Leonard J; Meyers G; Traer E; Press RD; Fan G; Wang Y; Raess PW; Maziarz RT; Dunlap J
Transplant Cell Ther; 2021 Aug; 27(8):662.e1-662.e9. PubMed ID: 33901720
[TBL] [Abstract][Full Text] [Related]
29. Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure.
Abplanalp WT; Cremer S; John D; Hoffmann J; Schuhmacher B; Merten M; Rieger MA; Vasa-Nicotera M; Zeiher AM; Dimmeler S
Circ Res; 2021 Jan; 128(2):216-228. PubMed ID: 33155517
[TBL] [Abstract][Full Text] [Related]
30. Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery Disease.
Büttner P; Böttner J; Krohn K; Baber R; Platzbecker U; Cross M; Desch S; Thiele H; Steiner S; Scheinert D; Metzeler KH; Branzan D
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835370
[TBL] [Abstract][Full Text] [Related]
31. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
[TBL] [Abstract][Full Text] [Related]
32. Characteristics and Outcome of Acute Heart Failure in Infective Endocarditis: Focus on Cardiogenic Shock.
Pericàs JM; Hernández-Meneses M; Muñoz P; Martínez-Sellés M; Álvarez-Uria A; de Alarcón A; Gutiérrez-Carretero E; Goenaga MA; Zarauza MJ; Falces C; Rodríguez-Esteban MÁ; Hidalgo-Tenorio C; Hernández-Cabrera M; Miró JM;
Clin Infect Dis; 2021 Sep; 73(5):765-774. PubMed ID: 33560404
[TBL] [Abstract][Full Text] [Related]
33. Estimation of Stressed Blood Volume in Patients With Cardiogenic Shock From Acute Myocardial Infarction and Decompensated Heart Failure.
Whitehead EH; Thayer KL; Sunagawa K; Hernandez-Montfort J; Garan AR; Kanwar MK; Sinha SS; Mahr C; Kapur NK; Burkhoff D
J Card Fail; 2021 Oct; 27(10):1141-1145. PubMed ID: 33862252
[TBL] [Abstract][Full Text] [Related]
34. Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure.
Mooney L; Goodyear CS; Chandra T; Kirschner K; Copland M; Petrie MC; Lang NN
Clin Sci (Lond); 2021 Apr; 135(7):991-1007. PubMed ID: 33861346
[TBL] [Abstract][Full Text] [Related]
35. Circulating angiopoietins and cardiovascular mortality in cardiogenic shock.
Link A; Pöss J; Rbah R; Barth C; Feth L; Selejan S; Böhm M
Eur Heart J; 2013 Jun; 34(22):1651-62. PubMed ID: 23349297
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations.
Calvillo-Argüelles O; Schoffel A; Capo-Chichi JM; Abdel-Qadir H; Schuh A; Carrillo-Estrada M; Liu S; Gupta V; Schimmer AD; Yee K; Shlush LI; Natarajan P; Thavendiranathan P
JACC CardioOncol; 2022 Mar; 4(1):38-49. PubMed ID: 35492819
[TBL] [Abstract][Full Text] [Related]
37. Mortality in patients with cardiogenic shock supported with VA ECMO: A systematic review and meta-analysis evaluating the impact of etiology on 29,289 patients.
Alba AC; Foroutan F; Buchan TA; Alvarez J; Kinsella A; Clark K; Zhu A; Lau K; McGuinty C; Aleksova N; Francis T; Stanimirovic A; Vishram-Nielsen J; Malik A; Ross HJ; Fan E; Rac VE; Rao V; Billia F
J Heart Lung Transplant; 2021 Apr; 40(4):260-268. PubMed ID: 33551227
[TBL] [Abstract][Full Text] [Related]
38. Genetic Heterogeneity in Chronic Myeloid Leukemia: How Clonal Hematopoiesis and Clonal Evolution May Influence Prognosis, Treatment Outcome, and Risk of Cardiovascular Events.
Sant'Antonio E; Camerini C; Rizzo V; Musolino C; Allegra A
Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):573-579. PubMed ID: 34078586
[TBL] [Abstract][Full Text] [Related]
39. Murine models of clonal haematopoiesis to assess mechanisms of cardiovascular disease.
Wang Y; Sano S; Ogawa H; Horitani K; Evans MA; Yura Y; Miura-Yura E; Doviak H; Walsh K
Cardiovasc Res; 2022 May; 118(6):1413-1432. PubMed ID: 34164655
[TBL] [Abstract][Full Text] [Related]
40. Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation.
Oran B; Champlin RE; Wang F; Tanaka T; Saliba RM; Al-Atrash G; Garcia-Manero G; Kantarjian H; Cao K; Shpall EJ; Alousi AM; Mehta RS; Popat U; Futreal A; Takahashi K
Leukemia; 2022 Jan; 36(1):257-262. PubMed ID: 34135465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
